Anticancer Effect of Pacificusoside D from the Starfish Solaster pacificus in Combination with 2-Deoxy-D-glucose on Oxidative Phosphorylation in Triple-Negative Breast Cancer Cells MDA-MB-231
Open Access
- 11 February 2026
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 24 (2) , 75
Abstract
Triple-negative breast cancer (TNBC) represents significant therapeutic challenges due to its aggressive behavior, metabolic plasticity, and lack of targeted treatments, prompting investigation of biologically active triterpene glycosides from the starfish Solaster pacificus. This study evaluated the ability of pacificusoside D (SpD) to synergistically enhance the anticancer efficacy of the glycolytic inhibitor 2-deoxy-D-glucose (2-DG) in TNBC MDA-MB-231 cells by targeting mitochondrial oxidative phosphorylation (OXPHOS). Methods included metabolic profiling via glucose uptake, lactate, and glutamate Glo assays; IC50 determination by MTS and trypan blue assays; colony formation evaluation using a soft agar assay; and molecular mechanism elucidation by Western blot, fluorescence microscopy and spectrometry, and flow cytometry analyses. Results demonstrated that MDA-MB-231 cells predominantly utilized glycolysis under basal conditions, shifting to OXPHOS with 2-DG (0.5 mM). IC50 values were 8.0/8.4 mM for 2-DG and 0.3/0.25 μM for SpD after 24 h of cell treatment. SpD exhibited a significant decrease in the number of colonies in MDA-MB-231 cells and possessed synergistic anticancer effects with 2-DG. Mechanistically, SpD increased tumor suppressor VHL expression level, down-regulated expression level of electron transport chain enzymes, generated reactive oxygen species, induced mitochondrial dysfunction, and triggered Bax/Bak-mediated apoptosis. These findings highlighted the synergistic anticancer potential of SpD in combination with 2-DG in aggressive breast cancer, offering insights into improved clinical outcomes in the future.Keywords
Funding Information
- Russian Science Foundation (25-14-00100)
This publication has 64 references indexed in Scilit:
- Metabolic reprogramming in breast cancer: Pathways driving progression, drug resistance, and emerging therapeuticsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistanceCancer and Metastasis Reviews, 2024
- Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infectionBiomedicine & Pharmacotherapy, 2022
- Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membraneBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- Chemical Constituents and Bioactivities of Starfishes: An UpdateChemistry & Biodiversity, 2020
- Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cellsBreast Cancer Research and Treatment, 2018
- Natural products: A continuing source of novel drug leadsBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Endoplasmic reticulum stress induced by 2-deoxyglucose but not glucose starvation activates AMPK through CaMKKβ leading to autophagyBiochemical Pharmacology, 2013
- Glycolysis inhibition by 2-deoxy-d-glucose reverts the metastatic phenotype in vitro and in vivoClinical & Experimental Metastasis, 2011
- Ptilomycalin A, crambescidin 800 and related new highly cytotoxic guanidine alkaloids from the starfishes Fromia monilis and Celerina heffernaniTetrahedron, 1995